Utility of transcranial sonography in the diagnosis of drug-induced parkinsonism: a prospective study

被引:12
作者
Olivares Romero, J. [1 ]
Arjona Padillo, A. [1 ]
Barrero Hernandez, F. J. [2 ]
Martin Gonzalez, M. [1 ]
Gil Extremera, B. [3 ]
机构
[1] Hosp Torrecardenas, Almeria, Spain
[2] Hosp San Cecilio, Granada, Spain
[3] Univ Granada, Sch Med, Granada, Spain
关键词
drug-induced parkinsonism; lentiform nucleus; nigrostriatal pathway; substantia nigra; transcranial sonography; SUBSTANTIA-NIGRA HYPERECHOGENICITY; MIDBRAIN SONOGRAPHY; MOVEMENT-DISORDERS; DISEASE; SPECT; ECHOGENICITY; ULTRASOUND; DUPLEX; RISK;
D O I
10.1111/ene.12131
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Background and purposeDrug-induced parkinsonism usually resolves after discontinuation of the causative agent. However, it persists in some patients, who actually have subclinical neurodegenerative parkinsonism. Identification of this condition is important because these patients could benefit from therapeutic measures. The objective of this study was to prove whether transcranial sonography, a technique used in the diagnosis of neurodegenerative parkinsonism, can be used for the said identification. MethodsIn this prospective study, patients with drug-induced parkinsonism were followed for at least 6months after discontinuation of the causative drug and performance of blinded transcranial sonography. Patients were categorized as having iatrogenic parkinsonism if the clinical presentation had resolved or subclinical drug-exacerbated parkinsonism if it persisted. Once the patient was classified into one of the two groups, an expert assessed the transcranial sonography findings and their agreement with the clinical diagnosis. ResultsTwenty patients composed the group for analysis of results. Assessing hyperechogenicity in the substantia nigra >20mm(2) and/or hyperechogenic lentiform nucleus, differences were detected between the iatrogenic parkinsonism and the subclinical drug-exacerbated parkinsonism groups, although they did not reach statistical significance (Fisher's exact test 0.09). Joint assessment of sonographic alterations in both structures had a negative predictive value of 85.7% for diagnosis of drug-induced parkinsonism, with a negative likelihood ratio of 0.3. ConclusionsAlthough in our study statistically significant differences were not found between the transcranial sonography characteristics of subclinical drug-exacerbated parkinsonism and iatrogenic parkinsonism patients, we believe that transcranial sonography is a valid technique for diagnosis of drug-induced parkinsonism. Click here to view the accompanying paper in this issue.
引用
收藏
页码:1451 / 1458
页数:8
相关论文
共 30 条
[1]
Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing [J].
Behnke, S. ;
Double, K. L. ;
Duma, S. ;
Broe, G. A. ;
Guenther, V. ;
Becker, G. ;
Halliday, G. M. .
NEUROIMAGE, 2007, 34 (03) :1054-1059
[2]
Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy [J].
Berg, D ;
Jabs, B ;
Merschdorf, U ;
Beckmann, H ;
Becker, G .
BIOLOGICAL PSYCHIATRY, 2001, 50 (06) :463-467
[3]
Enlarged Substantia Nigra Hyperechogenicity and Risk for Parkinson Disease A 37-Month 3-Center Study of 1847 Older Persons [J].
Berg, Daniela ;
Seppi, Klaus ;
Behnke, Stefanie ;
Liepelt, Inga ;
Schweitzer, Katherine ;
Stockner, Heike ;
Wollenweber, Frank ;
Gaenslen, Alexandra ;
Mahlknecht, Philipp ;
Spiegel, Joerg ;
Godau, Jana ;
Huber, Heiko ;
Srulijes, Karin ;
Kiechl, Stefan ;
Bentele, Marianna ;
Gasperi, Arno ;
Schubert, Teresa ;
Hiry, Teresa ;
Probst, Mareike ;
Schneider, Vera ;
Klenk, Jochen ;
Sawires, Martin ;
Willeit, Johann ;
Maetzler, Walter ;
Fassbender, Klaus ;
Gasser, Thomas ;
Poewe, Werner .
ARCHIVES OF NEUROLOGY, 2011, 68 (07) :932-937
[4]
Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France [J].
Bondon-Guitton, Emmanuelle ;
Perez-Lloret, Santiago ;
Bagheri, Haleh ;
Brefel, Christine ;
Rascol, Olivier ;
Montastruc, Jean-Louis .
MOVEMENT DISORDERS, 2011, 26 (12) :2226-2231
[5]
The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism [J].
Booij, J ;
Speelman, JD ;
Horstink, MWIM ;
Wolters, EC .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (03) :266-272
[6]
Failure of recognition of drug-induced parkinsonism in the elderly [J].
Esper, Christine D. ;
Factor, Stewart A. .
MOVEMENT DISORDERS, 2008, 23 (03) :401-404
[7]
Role of Transcranial Ultrasound in the Diagnosis of Movement Disorders [J].
Godau, Jana ;
Berg, Daniela .
NEUROIMAGING CLINICS OF NORTH AMERICA, 2010, 20 (01) :87-+
[8]
Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles [J].
Hagenah, Johann M. ;
Koenig, Inke R. ;
Becker, Bjoern ;
Hilker, Ruediger ;
Kasten, Meike ;
Hedrich, Katja ;
Pramstaller, Peter P. ;
Klein, Christine ;
Seidel, Guenter .
JOURNAL OF NEUROLOGY, 2007, 254 (10) :1407-1413
[9]
FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up [J].
Hambye, Anne-Sophie ;
Vervaet, Ann ;
Dethy, Sophie .
NUCLEAR MEDICINE COMMUNICATIONS, 2010, 31 (06) :583-589
[10]
Susceptibility to neuroleptic-induced parkinsonism - age and increased substantia nigra echogenicity as putative risk factors [J].
Jabs, BE ;
Bartsch, AJ ;
Pfuhlmann, B .
EUROPEAN PSYCHIATRY, 2003, 18 (04) :177-181